Abstract:Introduction: Synovial sarcoma (SySa) is a rare malignant soft tissue tumor characterized by a specific reciprocal translocation t(X;18). The resulting chimeric SS18::SSX fusion protein drives SySa tumorigenesis by integrating into BAF chromatin remodeling complexes, changing their composition and dysregulating gene transcription. The role of BAF complexes in cancer steadily increases with ∼20% of all malignancies having alterations in BAF complex subunits. BAF complexes are multiprotein complexes with several interaction partners determining their localization and functionality. Since previous analyses revealed an induced activation of the transcriptional coregulators YAP1 and β-catenin in SySa, the aim of this study was to analyze if nuclear YAP1 and β-catenin are interacting with BAF complexes and if this has an impact on their transcriptional activity. Experimental procedures: Co-immunoprecipitation experiments on nuclear protein extracts and proximity ligation assays were performed to investigate interactions between YAP1, β-catenin, and BAF complex subunits in SySa cells. Knockdown of common and specific BAF complex subunits was conducted employing RNA interference. To assess changes in YAP1 and β-catenin transcriptional activities, TEAD and TOPFlash luciferase reporter assays were performed, respectively, and protein expression levels were detected by immunoblotting. Results: In SySa, protein-protein interaction experiments revealed nuclear interactions between β-catenin, YAP1, the SS18::SSX fusion protein and various BAF subunits. YAP1 and β-catenin's transcriptional activities were found to be interdependent as they mutually enhanced each other's activation. Knockdown of SS18::SSX as well as specific BAF complex subunits was associated with diminished transcriptional activities of these coregulators and, interestingly, substantially affected their mutual activation. This indicates that SS18::SSX-containing BAF complex assembly is crucial for interdependent YAP1 and β-catenin activation in SySa cells. Conclusions: This study reveals a significant role of the SySa-specific fusion protein and BAF chromatin remodeling complexes in mediating intertwined activation of YAP1 and β-catenin. Citation Format: Ilka Isfort, Ruth Berthold, Lorena Heinst, Anna Kuntze, Eva Wardelmann, Marcel Trautmann, Wolfgang Hartmann. The BAF complex mediates intertwined activity of YAP1 and β-catenin in synovial sarcoma [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2024; Part 1 (Regular s); 2024 Apr 5-10; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2024;84(6_Suppl) nr 5638.

SS18::SSX redistributes BAF chromatin remodelers selectively to activate and repress transcription

Synovial Sarcoma Chromatin Dynamics Reveal a Continuum in SS18:SSX Reprograming

Abstract 5638: The BAF complex mediates intertwined activity of YAP1 and β-catenin in synovial sarcoma

Cell-of-origin epigenome underlies SS18::SSX-mediated transformation

Targeting of SUMOylation leads to cBAF complex stabilization and disruption of the SS18::SSX transcriptome in Synovial Sarcoma

The chromatin landscape of primary synovial sarcoma organoids is linked to specific epigenetic mechanisms and dependencies

Subnuclear Distribution of SSX Regulates Its Function.

Condensate remodeling reorganizes innate SS18 in synovial sarcomagenesis

Phase transition and remodeling complex assembly are important for SS18-SSX oncogenic activity in synovial sarcomas

Synovial sarcoma X breakpoint 1 protein uses a cryptic groove to selectively recognize H2AK119Ub nucleosomes

Syt-Ssx Is Critical For Cyclin D1 Expression In Synovial Sarcoma Cells: A Gain Of Function Of The T(X;18)(P11.2;Q11.2) Translocation

SYT-SSX1 enhances the invasiveness and maintains stem-like cell properties in synovial sarcoma via induction of TGF-β1/Smad signaling

Co-existence of SYT-SSX1 and SYT-SSX2 fusions in synovial sarcomas.

Identification of Shcbp1 As A Novel Downstream Target Gene of Ss18-Ssx1 and Its Functional Analysis in Progression of Synovial Sarcoma

Abstract 7071: Pharmacological targeting of SUMOylation leads to cBAF complex stabilization and disruption of the synovial sarcoma signature

Gene Expression Profile by Blocking the SYT-SSX Fusion Gene in Synovial Sarcoma Cells. Identification of XRCC4 As a Putative SYT-SSX Target Gene

Systematic Transcriptome Analysis of Synovial Sarcoma Reveals Novel Transcriptional And Post-Transcriptional Abnormalities

SS18-SSX-Dependent YAP/TAZ Signaling in Synovial Sarcoma

A SALL4/MLL/HOXA9 Pathway in Murine and Human Myeloid Leukemogenesis.

Characteristic sequence motifs located at the genomic breakpoints of the translocation t(X;18) in synovial sarcomas

Transcriptomic Profiling of Synovial Sarcoma Reveals Novel Transcriptional and Post-Transcriptional Abnormalities